Kazia Therapeutics Appoints James Levine as Chief Financial Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. AKAM
2. COST
3. SPY
4. ZS
5. NVDA
6. META
7. DRI
8. ULS
9. VEON
10. PRME

Go back to Kazia Therapeutics Appoints James Levine as Chief Financial Officer
(NASDAQ: KZIA) Delayed: 9.76 -0.02 (0.2%)
Previous Close $9.78    52 Week High $ 
Open $9.77    52 Week Low $ 
Day High $9.99    P/E N/A 
Day Low $9.60    EPS $ 
Volume 76,144